BioMarin Pharmaceutical Inc. (BMRN) Financials

BMRN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 11.7 billion 5.4 billion
March 31, 2026 8.6 billion 2.4 billion
Dec. 31, 2025 7.6 billion 1.5 billion
Sept. 30, 2025 7.6 billion 1.6 billion

BMRN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 139.3 million 75.7 million
March 31, 2026 199.7 million 43.5 million
Dec. 31, 2025 58.9 million 46.9 million
Sept. 30, 2025 334.9 million 49.3 million

BMRN Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 44.8 million
March 31, 2026 105.5 million
Dec. 31, 2025 139.1 million
Sept. 30, 2025 -30.7 million

BMRN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 874.0 million 3.5 billion 16.1 million
March 31, 2026 2.2 billion 1.4 billion 9.3 million
Dec. 31, 2025 1.6 billion 597.2 million 37.0 million
Sept. 30, 2025 1.5 billion 596.7 million 7.6 million

BMRN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 194.1 million
March 31, 2026 197.7 million
Dec. 31, 2025 197.4 million
Sept. 30, 2025 192.0 million

BMRN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 28.8 million 207.0 million 395.5 million 142.2 million
March 31, 2026 20.9 million 178.8 million 258.3 million 124.9 million
Dec. 31, 2025 40.7 million 192.4 million 802.1 million -
Sept. 30, 2025 33.8 million 409.5 million 268.4 million 131.3 million

BMRN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 989.7 million 202.8 million
March 31, 2026 766.2 million 195.0 million
Dec. 31, 2025 874.6 million 295.1 million
Sept. 30, 2025 776.1 million 140.1 million

BMRN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

BMRN

Price: $67.36

52 week price:
49.26
70.98

Earnings Per Share: 0.37 USD

P/E Ratio: 189.84

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.1 million

Ebitda: 11.0 million

Market Capitalization: 13.6 billion

Links: